Tesera implants feature porous titanium surfaces which create the optimal environment for bone on-growth and in-growth. Tesera implants combine revolutionary manufacturing technology, advanced material science and bio-analogous design into cutting-edge implants that push the expectations of how spinal implants interact with the body.
Tesera® porous titanium interbody fusion systems feature implants for direct posterior (PLIF) or transforaminal (TLIF) approaches in both straight and curved options. Multiple heights, widths and lengths are available to better fit varying patient anatomies. All Tesera implants feature additive manufacturing (3D printing) and the company’s proprietary Tesera Trabecular Technology®, a highly porous structure that allows for bone attachment to the implant surfaces and the potential for biologic fixation deep into the pore structure for long-term stability.
For more information on the Tesera® porous structure, visit http://www.teseratrabeculartechnology.com.
Renovis is committed to advancing patient care through better products, based on scientific and clinical data. We commissioned an independent study through IMDS Discovery Research to validate our Tesera™ technology. Below are images and excerpts from the 12-Week Draft Report.
Tesera Trabecular Technology
- Optimal environment for bone IN-GROWTH and ON-GROWTH
- 3D-printed Titanium-alloy (Ti6Al4V)
- Truly-porous trabecular structure
- Random, interconnected pores (500 micron average pore size)
- 68% Average Porosit
- Hydroxyapetite-blasted, for micro-surface roughness
About Renovis Surgical
Renovis Surgical Technologies, Inc. was founded in 2009 with the express mission of creating the highest quality implants for orthopedics, spine and trauma. The company has headquarters in Redlands, California, with additional operations in Austin, Texas.For additional information on the Company, please visit http://www.renovis-surgical.com.